1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Myoclonic Seizures Global Clinical Trials Review, H2, 2014

Myoclonic Seizures Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Myoclonic Seizures Global Clinical Trials Review, H2, 2014" provides data on the Myoclonic Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonic Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonic Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Myoclonic Seizures Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Myoclonic Seizures 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Myoclonic Seizures 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Myoclonic Seizures Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
UCB S.A. 30
Clinical Trial Overview of UCB S.A. 30
Biocodex SA 31
Clinical Trial Overview of Biocodex SA 31
Teva Pharmaceutical Industries Limited 32
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 32
Sky Growth Acquisition Corporation 33
Clinical Trial Overview of Sky Growth Acquisition Corporation 33
GW Pharmaceuticals plc 34
Clinical Trial Overview of GW Pharmaceuticals plc 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Desitin Arzneimittel GmbH 36
Clinical Trial Overview of Desitin Arzneimittel GmbH 36
Bluefish Pharmaceuticals AB 37
Clinical Trial Overview of Bluefish Pharmaceuticals AB 37
Adamed Sp. z o.o. 38
Clinical Trial Overview of Adamed Sp. z o.o. 38
Clinical Trial Overview of Top Institutes / Government 39
National Institute of Neurological Disorders and Stroke 39
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 39
University of Colorado Denver 40
Clinical Trial Overview of University of Colorado Denver 40
Shizuoka University 41
Clinical Trial Overview of Shizuoka University 41
Institut National de la Sante et de la Recherche Medicale 42
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 42
University of Turku 43
Clinical Trial Overview of University of Turku 43
Five Key Clinical Profiles 44
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 7
Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Myoclonic Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 30
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocodex SA, 2014* 31
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 32
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Sky Growth Acquisition Corporation, 2014* 33
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2014* 34
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Desitin Arzneimittel GmbH, 2014* 36
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 37
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Adamed Sp. z o.o., 2014* 38
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 39
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2014* 40
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shizuoka University, 2014* 41
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014* 42
Myoclonic Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turku, 2014* 43

List of Figures
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Myoclonic Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myoclonic Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Myoclonic Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Myoclonic Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Myoclonic Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Myoclonic Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Myoclonic Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Myoclonic Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Myoclonic Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Myoclonic Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Myoclonic Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Myoclonic Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Myoclonic Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Myoclonic Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Myoclonic Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Myoclonic Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 56

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.